
Parexel International Allies with Mortara Instrument
"This relationship represents our commitment to providing comprehensive early phase cardiovascular expertise and capabilities, such as intensive ECG and thorough QT/QTc studies, supported by enabling technologies,” said Michelle Middle, Parexel's corporate VP and worldwide head of early phase, in a company press release.
Mortara's high-tech solution will automate the process of acquiring and recording ECGs for Parexel, which are wirelessly transmitted from devices worn by clinical trial participants.




